You have 4 free searches left this month | for more free features.

City

Nanjing (1)

Condition

Carcinoma, Non-Small-Cell Lung (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

The First Affiliated Hospital with Nanjing Medical University (1)

Collaborator

Intervention

fruquintinib,sintilimab,pemetrexed,carboplatin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

fruquintinib，sintilimab，pemetrexed，carboplatin

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Nanjing (Fruquintinib,Sintilimab,Pemetrexed,Carboplatin)

Recruiting

Carcinoma, Non-Small-Cell Lung

Fruquintinib，Sintilimab，Pemetrexed，Carboplatin

Nanjing, Jiangsu, China

Jiangsu Province Hospital

Feb 11, 2022